Clofenciclan
Appearance
![]() | |
Clinical data | |
---|---|
Trade names | Tonquil, Vesitan |
Other names | Chlorphencyclan |
Routes of administration | Oral |
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C18H28ClNO |
Molar mass | 309.88 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Clofenciclan (also known as chlorphencyclan; trade names Tonquil and Vesitan) is a dopamine-releasing agent developed by Boehringer & Soehne in the 1950s.[1][2] It proved unpopular as a treatment because of its pronounced stimulant activity.[3]
Sila analogues of clorphencyclane were developed.[4]
See also
[edit]References
[edit]- ^ Stach, K., Winter, W. (January 1962). "[New therapeutically active basic ethers. 1. 1-Arylcycloalkanol derivatives]". Arzneimittel-Forschung. 12: 25–29. PMID 13916036.
- ^ U.S. patent 3,254,083
- ^ Poeldinger W (January 1962). "[Therapeutic experiences with thiopropazate and with a combination of thiopropazate and chlorphencyclan (Vesitan) in psychiatry]". Praxis (in German). 51: 73–8. PMID 14487367.
- ^ Ackermann J, Tacke R, Wannagat U, Koke U, Meyer F. Sila-Pharmaka, 12. Mitt. Sila-Analoga des Chlorphencyclans [Sila drugs, XII: Sila analogues of clorphencyclane (author's transl)]. Arch Pharm (Weinheim). 1980 Feb;313(2):129-41. German. doi: 10.1002/ardp.19803130206. PMID: 7369832.